Secukinumab in the Treatment of Generalized Pustular Psoriasis
References
- Rivera-Díaz R, Daudén E, Carrascosa JM, Cueva P, Puig L. Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb). 2023;13(3):673-88.
- Yücesoy SN, Engin B. The treatment options for generalized pustular psoriasis. Journal of the Turkish Academy of Dermatology. 2023;17(3):59-61.
- Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021; 9(11):1511.
- Blauvelt A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, et al. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: results from the CLEAR study. J Am Acad Dermatol. 2017;76(1):60-69.e9.
- Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263-71.
- Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, et al. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol. 2011;186(4):2613-22.
- Ratnarajah K, Jfri A, Litvinov IV, Netchiporouk E. Spesolimab: a novel treatment for pustular psoriasis. J Cutan Med Surg. 2020;24(2):199-200.
- Furue K, Yamamura K, Tsuji G, Mitoma C, Uchi H, Nakahara T, et al. Highlighting interleukin-36 signalling in plaque psoriasis and pustular psoriasis. Acta Derm Venereol. 2018;98(1):5-13.
- Johnston A, Xing X, Wolterink L, Barnes DH, Yin Z, Reingold L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109-20.
- Mercurio L, Failla CM, Capriotti L, Scarponi C, Facchiano F, Morelli M, et al. Interleukin (IL)-17/IL-36 axis participates in the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses. PLoS One. 2020;15(4):e0222969.
- Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O’Toole M, et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol. 2011;131 (12):2428-37.
- Böhner A, Roenneberg S, Eyerich K, Eberlein B, Biedermann T. Acute generalized pustular psoriasis treated with the IL-17A antibody secukinumab. JAMA Dermatol. 2016;152(4):482-4.
- Madanagobalane S. Secukinumab in generalized pustular psoriasis. Indian Dermatol Online J. 2018;9(6): 464-6.
- Polesie S, Lidholm AG. Secukinumab in the treatment of generalized pustular psoriasis: a case report. Acta Derm Venereol. 2017;97(1):95-6.
- Zhu H, Song P, Du D, Tian H. Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy. Pediatr Dermatol. 2021;38(5):1366-7.
- Xue G, Lili M, Yimiao F, Miao W, Xiaohong Y, Dongmei W. Case report: successful treatment of acute generalized pustular psoriasis of puerperium with secukinumab. Front Med (Lausanne). 2022;9:1072039.
- Yu K, Bao H, Wu X. Successful treatment of pediatric generalized pustular psoriasis with secukinumab. Clin Cosmet Investig Dermatol. 2025;18:105-8.
- Miao C, Chen Y, Wang Z, Xiang X, Liu Y, Xu Z. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis. J Dermatol. 2023;50(2):258-61.
- Singla S, Luz D. Paradoxical psoriasis with IL-17 inhibitors. Rheumatol Adv Pract. 2024;8(3):rkae082.
- Yatsuzuka K, Muto J, Shiraishi K, Fujisawa Y, Murakami M. Paradoxical eczema associated with interleukin-17A inhibitor use in a patient with generalized pustular psoriasis accompanied by asthma. Cureus. 2024; 16 (7):e64680.
Language: English
Page range: 11 - 18
Submitted on: Nov 9, 2025
Accepted on: Nov 12, 2025
Published on: Aug 19, 2026
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Vesna Miličić, Kristina Andrić, Željko Mijušković, Miroslav Dinić, Ana Ravić Nikolić, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.